Status:
UNKNOWN
Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache
Lead Sponsor:
Pamukkale University
Conditions:
Headache, Migraine
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
* Currently, paracetamol and nonsteroidal antiinflammatory drugs are widely used by emergency physicians in Turkey for the treatment of patients with Acute Migraine Attack Headache * The objective of ...
Detailed Description
* This is the randomized double blinded clinical trial to compare the efficacy of these three drugs in this clinical setting. * A randomized clinical trial was conducted in the Emergency Department (E...
Eligibility Criteria
Inclusion
- Patients were eligible for inclusion if they were aged 18 years or older, 65 years or younger
- Isolated Migraine Attack Headache
- Patients who agree to work and receive the approval
- VAS (visual analog scale) score\>5.
Exclusion
- Patients with severe liver, kidney,pulmonary and cardiac heartfailure
- To be Pregnancy and breast-feeding
- Have received analgesics in the last 6hours
- Patients of childbearing age who are not using a birth control method.
- Patients with neurological deficits
- Patients with cardiac chest pain
- Patients with chronic pain
- Patients with pre-existing ibuprofen, dexketoprofen and paracetamol-induced gastrointestinal bleeding and perforation
- Patients with reflected pain
- Patients with neoplastic pain
- Patients with an allergy trait (ibuprofen, paracetamol and dexketoprofen)
- Illiterates and patients with vision problems
Key Trial Info
Start Date :
October 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 29 2020
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04372264
Start Date
October 15 2018
End Date
December 29 2020
Last Update
October 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamukkale University
Denizli, Turkey (Türkiye), 20070